Your browser doesn't support javascript.
loading
Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi, N; Sonomura, Y; Kato, H; Komuro, A; Kinoshita, S.
Affiliation
  • Yokoi N; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Sonomura Y; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kato H; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Komuro A; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kinoshita S; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Eye (Lond) ; 29(9): 1204-12, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26160526

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ophthalmic Solutions / Polyphosphates / Uracil Nucleotides / Dry Eye Syndromes / Sjogren's Syndrome / Lubricant Eye Drops Type of study: Etiology_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2015 Document type: Article Affiliation country: Japón Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ophthalmic Solutions / Polyphosphates / Uracil Nucleotides / Dry Eye Syndromes / Sjogren's Syndrome / Lubricant Eye Drops Type of study: Etiology_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2015 Document type: Article Affiliation country: Japón Country of publication: Reino Unido